Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population
Marlies M Kok, Clemens von Birgelen, Naveed Sattar, Paolo Zocca, Marije M Lowik, Peter W Danse, Carl E Schotborgh, Martijn Scholte, Marc Hartmann, Gert D Kant, Cees Doelman, Melvyn Tjon Joe Gin, Martin G Stoel, Gert van Houwelingen, Gerard CM Linssen, Maarten J IJerman, Carine JM Doggen, Liefke C van der Heijden
EUROINTERVENTION | EUROPA EDITION | Published : 2018
AIMS: It is unclear whether detection of prediabetes (pre-DM) by routine assessment of glycated haemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) among patients undergoing percutaneous coronary intervention (PCI) with contemporary drug-eluting stents (DES) may help identify subjects with increased event risk. We assessed the relation between glycaemia status and one-year outcome after PCI. METHODS AND RESULTS: Glycaemia status was determined in 2,362 non-diabetic BIO-RESORT participants, treated at all four study sites, to identify pre-DM (HbA1c 42-47 mmol/mol; FPG 6.1-6.9 mmol/L) and unknown diabetes mellitus (DM) (HbA1c ≥48 mmol/mol; FPG ≥7.0 mmol/L). Another 624 patients had medica..View full abstract
The BIO-RESORT study was funded equally by Biotronik, Boston Scientific, and Medtronic.